Pacer Advisors Inc. increased its position in shares of Monsanto Company (NYSE:MON) by 13.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,319 shares of the basic materials company’s stock after acquiring an additional 1,299 shares during the quarter. Pacer Advisors Inc.’s holdings in Monsanto were worth $1,356,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently modified their holdings of the company. P Schoenfeld Asset Management LP lifted its stake in Monsanto by 34.0% in the third quarter. P Schoenfeld Asset Management LP now owns 294,111 shares of the basic materials company’s stock valued at $35,240,000 after buying an additional 74,595 shares during the period. Vaughan David Investments Inc. IL lifted its stake in Monsanto by 1,058.1% in the third quarter. Vaughan David Investments Inc. IL now owns 256,932 shares of the basic materials company’s stock valued at $16,112,000 after buying an additional 234,746 shares during the period. Quantbot Technologies LP lifted its stake in Monsanto by 2,869.5% in the third quarter. Quantbot Technologies LP now owns 5,939 shares of the basic materials company’s stock valued at $711,000 after buying an additional 5,739 shares during the period. Cheyne Capital Management UK LLP lifted its stake in Monsanto by 172.1% in the third quarter. Cheyne Capital Management UK LLP now owns 651,500 shares of the basic materials company’s stock valued at $3,236,000 after buying an additional 412,083 shares during the period. Finally, Stratos Wealth Partners LTD. lifted its stake in Monsanto by 20.1% in the third quarter. Stratos Wealth Partners LTD. now owns 4,803 shares of the basic materials company’s stock valued at $576,000 after buying an additional 805 shares during the period. 75.70% of the stock is currently owned by institutional investors and hedge funds.
Shares of Monsanto Company (NYSE MON) traded down $0.08 during trading on Thursday, hitting $118.00. The company’s stock had a trading volume of 1,360,230 shares, compared to its average volume of 1,957,206. Monsanto Company has a 12 month low of $104.08 and a 12 month high of $122.79. The company has a market capitalization of $52,058.05, a P/E ratio of 21.39, a P/E/G ratio of 1.70 and a beta of 1.04. The company has a quick ratio of 0.83, a current ratio of 1.35 and a debt-to-equity ratio of 1.12.
Monsanto (NYSE:MON) last announced its quarterly earnings results on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.41) by $0.61. The company had revenue of $2.69 billion during the quarter, compared to the consensus estimate of $2.51 billion. Monsanto had a return on equity of 42.40% and a net margin of 15.44%. The company’s revenue for the quarter was up 4.8% compared to the same quarter last year. During the same period in the prior year, the company earned $0.07 earnings per share. equities research analysts expect that Monsanto Company will post 5.74 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, January 5th will be issued a dividend of $0.54 per share. The ex-dividend date is Thursday, January 4th. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.83%. Monsanto’s payout ratio is presently 42.27%.
Several equities analysts have weighed in on MON shares. Zacks Investment Research lowered Monsanto from a “buy” rating to a “hold” rating in a research note on Tuesday, September 12th. Wells Fargo & Company increased their target price on Monsanto from $107.50 to $118.00 and gave the company a “market perform” rating in a research note on Tuesday, October 10th. UBS lowered Monsanto from a “buy” rating to a “neutral” rating and set a $128.00 target price on the stock. in a research note on Friday, August 18th. BidaskClub raised Monsanto from a “sell” rating to a “hold” rating in a research note on Saturday, August 19th. Finally, Barclays reissued an “equal weight” rating and issued a $124.00 target price (up previously from $120.00) on shares of Monsanto in a research note on Thursday, October 5th. Eleven analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Monsanto presently has a consensus rating of “Hold” and an average price target of $124.61.
In related news, VP Duraiswami Narain sold 2,860 shares of the stock in a transaction dated Monday, September 25th. The stock was sold at an average price of $120.00, for a total transaction of $343,200.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Steven Mizell sold 11,526 shares of the stock in a transaction dated Monday, October 9th. The stock was sold at an average price of $119.70, for a total value of $1,379,662.20. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 49,236 shares of company stock valued at $5,931,934. 0.79% of the stock is owned by corporate insiders.
COPYRIGHT VIOLATION WARNING: “Pacer Advisors Inc. Buys 1,299 Shares of Monsanto Company (NYSE:MON)” was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this news story on another website, it was illegally copied and reposted in violation of international copyright & trademark laws. The original version of this news story can be read at https://www.dispatchtribunal.com/2017/12/07/pacer-advisors-inc-has-1-36-million-position-in-monsanto-company-mon.html.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.